MP-376
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Amgen
Overview
MP-376 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
MP-376 clinical trials
Explore related
Medical disclaimer. This page summarizes research about MP-376 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.